The Medical Devices Regulations require an establishment licence holder to keep a distribution record, handle complaints and report incidents. What changes on the compliance date is narrower than the headline suggests and more operational than most summaries say: the attestation that procedures exist is replaced by an explicit duty to establish, implement and maintain them, and a supplier list becomes a filed item that is refreshed every year. This article reads the amending instrument section by section, sets out the document and record fields an importer or distributor will be asked to produce, and settles the one date question the published record leaves open: the amendments take effect on 1 December 2026.
Quick facts
- The amending instrument is SOR/2026-110, Regulations Amending the Medical Devices Regulations (Establishment Licences), registered 4 June 2026 and published in the Canada Gazette, Part II on 17 June 2026 (Volume 160, Number 12).
- The amendments come into force on 1 December 2026. Section 10 provides that "These Regulations come into force on the 180th day after the day on which they are registered", and the instrument was registered on 4 June 2026.
- Health Canada's MDCP Bulletin of 17 June 2026 counts those 180 days from publication instead and writes "December 14, 2026, 180 days after being published in the Canada Gazette, Part II on June 17, 2026"; the instrument text governs, and the date to plan to is 1 December 2026.
- Three changes matter to an importer or distributor: the supplier list under paragraphs 45(f.1) and (f.2), the documented-procedure duties in subsections 52(3), 58, 58.1, 59(3), 59(4) and 61.2(4), and the narrowed verification duty in subsection 44(4).
- The regulatory impact analysis statement puts the population affected at roughly 2,300 importers and distributors, of which about 800 already send supplier information voluntarily.
What does SOR/2026-110 actually change?
The instrument is short — ten sections plus a regulatory impact analysis statement — and it does two things. It removes a duplication in licensing for foreign distributors, and it converts an attestation regime into an explicit documentation regime. Everything else is consequential drafting.
Until the amendments take effect, subsection 44(3) requires any person who imports a medical device to verify that the person they import it from holds an establishment licence, and subsection 44(4) carves out narrow exceptions. Foreign distributors therefore need a licence of their own even where their only Canadian customer is a licensed importer. Section 1 of SOR/2026-110 replaces subsection 44(4) and adds a third exception: a person who imports any medical device from a person other than the manufacturer, and who holds an establishment licence, is no longer caught by subsection (3).
Section 2 is the part a buyer or importer will feel first. It repeals paragraph 45(e) — the medical specialities previously listed for each manufacturer — and it inserts two new paragraphs:
| New provision | Text of the requirement | What it means in practice |
|---|---|---|
| 45(f.1) | "the name and address of any person, other than the manufacturer, who sells a medical device to the establishment for the purposes of importation or distribution" | Every non-manufacturer seller in your inbound chain has to be named, with an address |
| 45(f.2) | "for each person referred to in paragraph (f.1)… the classes of the devices that are being imported or distributed" | Each of those sellers is tied to the device classes it supplies, not to a single blanket class |
Section 2 also repeals paragraphs 45(g) to (i), which were attestations by a senior official that procedures were in place for distribution records, complaint handling, recalls, incident reporting and, where applicable, handling, storage, delivery, installation, corrective action and servicing. In their place, the substantive sections of the Regulations impose the duty directly. Paragraph 45(j) is rewritten so that the application must give "the address of each building where the procedures described in any of sections 52, 58, 58.1 and subsections 59(3) and (4) and 61.2(4) are in place."
The practical reading is straightforward: the licence application no longer asserts that procedures exist; it points at the buildings where the specified procedures operate, and the procedures themselves are separately required. For a supplier to a clinic or a care home, that is a documentation question rather than a licensing question — a point worth raising with whoever holds the licence before the compliance date, since the consumables in scope range from Class I items such as nitrile examination gloves, 3.5 mil, 1,000 per case to Class II monitoring products such as 24-hour self-contained biological indicators — 25-pack.
When do the amendments come into force?
The instrument fixes one effective date. A Health Canada guidance document counts the same 180 days from a different anchor and prints a later date; the difference is worth understanding rather than smoothing over.
| Source | What it says | Date the source yields |
|---|---|---|
| Section 10 of SOR/2026-110 (instrument text) | "come into force on the 180th day after the day on which they are registered" | Registered 4 June 2026 → 1 December 2026 — effective date |
| Health Canada MDCP Bulletin, 17 June 2026 (guidance) | "December 14, 2026, 180 days after being published in the Canada Gazette, Part II on June 17, 2026" | Counted from publication on 17 June 2026 → 14 December 2026 |
The thirteen-day difference comes from the anchor date, not from arithmetic: section 10 counts from registration, while the bulletin counts from publication. The instrument text governs; the bulletin is the department's enforcement guidance, and its own sentence names the anchor it used. Plan for the documented procedures and the supplier data to be in place by 1 December 2026.
One more textual detail matters. As of mid-October 2026 the consolidated Medical Devices Regulations on the Department of Justice site are "current to 2026-09-30 and last amended on 2026-06-17", and the amended provisions appear on that site's list of amendments not in force, not in the body of the consolidated text. Anyone reading section 45 today and finding the old attestation paragraphs is reading the version still in effect, not a drafting error.
Which obligations become documented procedures?
Five provisions now require procedures in terms that did not previously appear. The table below maps the obligation to the provision, to the document you need, and to what an inspector can ask to see. Record content and retention come from the surrounding sections that already existed.
| Obligation | Provision (post-amendment) | Document to hold | Records the procedure has to produce | What an inspector asks for |
|---|---|---|---|---|
| Distribution records | 52(3), with 52(1), 53, 55 and 56 | Written procedure for creating, maintaining and retrieving the distribution record | Per device: enough information for a complete and rapid recall; retained for the longer of the projected useful life and two years after shipment; retrievable in a timely way | The procedure, plus a worked recall trace from a lot number back to the customer |
| Complaint investigation and recall | 58, with 57 | Written procedure covering investigation of reported problems and effective, timely recall | Complaint records: the reported problem, and every action taken in response | A complaint log with the investigation and the closure decision |
| Handling, storage, delivery, installation, servicing, corrective action | 58.1 (Class II, III and IV) | Written procedure, "as applicable", for each of the six activities | Evidence that the activity was performed as written | The procedure plus a completed service or corrective-action record |
| Incident reports | 59(3) for Class I; 59(4) for Class II, III and IV | Written procedure for making preliminary and final reports | Report drafts and the submission record, against the 10-day and 30-day clocks in section 60 | A report file showing the date awareness began and the date the report went in |
| Information on serious risk of injury | 61.2(4), with 61.2(2) and (3) | Written procedure for providing the information effectively and on time | The information received or become aware of, and the submission within 72 hours | The procedure plus a dated example of a submission |
Two features of this table are easy to miss. First, subsection 58.1 applies to manufacturers, importers and distributors of Class II, III and IV devices — a distributor of Class I devices does not carry that particular duty, though it still carries 52(3), 58 and, if it imports, 61.2(4). Second, the duty is to establish, implement and maintain. A procedure that exists in a binder but is not the one staff follow fails the second verb; a procedure that was correct in 2023 and has not been reviewed fails the third.
What must the supplier list contain?
Health Canada defines a supplier, for this purpose, as any person other than the manufacturer who sells a medical device to an establishment licence holder — which includes Canadian importers, domestic distributors and foreign distributors selling into Canada. The application instructions (FRM-0292, Section 5) set out the fields the form expects; the regulation sets out the two that are now mandatory in section 45.
| Field | Source | Who it covers | When it is refreshed |
|---|---|---|---|
| Name and address of each non-manufacturer seller | 45(f.1) | Every supplier in the inbound chain, including foreign distributors | At application and at each annual licence review |
| Device classes for each of those sellers | 45(f.2) | Each supplier, separately | Same |
| Name and address of each manufacturer | 45(d), unchanged | Manufacturers of the devices imported or distributed | Same |
| Device classes for each manufacturer | 45(f), unchanged | Each manufacturer | Same |
| Building addresses where the specified procedures operate | 45(j), as amended | Each site holding procedures under 52, 58, 58.1, 59(3), 59(4) and 61.2(4) | Same; a site marked inactive stays in the record until removed |
| Senior official attestation | FRM-0292, Section 6 | The person with direct knowledge of the procedures | Every application type except cancellation |
Section 3 of the instrument rewrites subsection 46.1(1) so that the annual review application "include[s] with it the information and documents referred to in section 45, including any updates". The review is still due before 1 April each year. That makes the supplier list a recurring filing rather than a one-time registration — the regulatory impact analysis statement estimates that an organisation listed eleven suppliers on its initial list and updated or added about two during the annual review.
The same statement sets expectations for the workload: roughly 240 new applications a year at about $400 each, about 1,260 annual updates at about $70 each, and a first-year sector cost of roughly $600,000. It expects no incremental cost for the documented procedures themselves, on the basis that Class II to IV manufacturers already maintain them under a quality management system audited through MDSAP.
Does the foreign distributor still need an MDEL?
Sometimes. The change is narrower than the phrase "foreign distributors no longer need a licence" implies, and the distinction is in who the foreign distributor sells to.
| Situation | Before the amendments | After the amendments |
|---|---|---|
| Foreign distributor sells only to a Canadian importer that holds an establishment licence | Both the foreign distributor and the Canadian importer needed a licence | The Canadian importer's licence is sufficient; the foreign distributor does not need one |
| Foreign distributor sells to Canadian health care facilities, retailers or other persons that do not hold a licence | Licence required | Licence still required |
| Canadian importer holding a licence buys from a non-manufacturer abroad | Had to verify the seller held a licence | No verification duty under 44(3); the supplier is recorded under 45(f.1) instead |
| Retailer or health care facility importing without a licence | Had to verify the seller held a licence | Still must verify it — the exemption in 44(4) does not reach them |
The regulatory impact analysis statement is explicit that "persons without an MDEL that import (i.e. retailers and health care facilities) will continue to be required to verify that the foreign distributor whom they import from holds an MDEL." The departmental guidance table says the same thing in operational language: a seller outside Canada that sells "solely to importers in Canada that have an MDEL" needs no licence; one that sells to facilities, retailers or other non-licensees does.
There is a transitional provision as well. Section 9 covers an application submitted before the compliance date on which no decision has been made: the licence is not to be issued unless the applicant has provided the 45(f.1) and (f.2) supplier information in the form the Minister establishes.
How should an importer prepare before the date?
Work backwards from the record, not forwards from the regulation.
- List every non-manufacturer seller in your inbound chain by legal name and address, including affiliated distributors that were previously covered by their own licence. Mark which of them still need a licence because they also sell to facilities or retailers.
- Attach device classes to each seller and to each manufacturer, using the class recorded on the device labelling and, for Class II to IV devices, the company identification number in the Medical Devices Active Licence Listing.
- Take the five procedure families in the table above and check each one exists, is current, and is the version staff actually use. A procedure with no evidence of use is a finding waiting to happen.
- Confirm the building addresses in 45(j) match where the procedures are actually operated — a third-party warehouse running your storage procedure belongs in that list.
- Put the annual review on a calendar with a February internal deadline, so the 1 April filing is a confirmation rather than a compilation.
- Check whether any device you handle falls outside the licensing framework altogether. Prescription eyewear, for example, sits outside it: flip-up dental loupes — 2.5× with wireless headlight are not a medical device in Canada, so the question is whether they are being imported as an accessory to something that is.
What will an inspector ask for?
The application instructions state that during a regulatory inspection, inspectors "may request a copy of the MDEL application submitted to Health Canada for review and copies of documented procedures in place at each site", and that establishments must have this information available. The same document warns that false or misleading statements in an application can lead to refusal under subsection 47(1) or suspension under paragraph 49(1)(b).
In practice that means four artefacts: the filed application, the current supplier and manufacturer list with classes, the five procedures at the version in force, and the records those procedures generate. A recall trace that runs forwards and backwards exercises all of them at once, which is why it is the most persuasive thing you can hand over. The same discipline applies to the records a clinic keeps at the point of use: the printable sterilization log sheets and the free log generator exist so that a traceable record is completed as the work happens rather than reconstructed afterwards.
None of this is legal advice, and nothing here substitutes for the text of the instrument or for advice from your regulatory affairs lead. The purpose is narrower: a section-by-section map with the primary sources attached, so the work can start before the date rather than after it. Buyers who want the licensing basics can start with what an MDEL is and who needs one, and institutional accounts that buy through a distributor rather than importing directly can find the account route on the wholesale and institutional supply page. Reselling? become a distributor.
Related reading
- What Is an MDEL? Canada's Medical Device Establishment Licence Explained
- Medical Device Establishment Licensing in Canada vs FDA Registration
- MDSAP, EU MDR and Health Canada: How One Device Is Regulated Under Three Regimes
- Direct Importer or Distributor: Which Supply Channel Fits a Canadian Clinic?
Frequently Asked Questions
Does SOR/2026-110 apply to clinics that buy from a Canadian distributor?
The amendments regulate establishment licence holders and people who import. A clinic that buys from a licensed Canadian distributor without importing is not the regulated party under these provisions. The clinic is, however, the customer whose complaints and incident reports feed the distributor's section 58 and section 59 records, and it can reasonably ask to see how those are handled.
Is the supplier list the same as the list of manufacturers?
No. Manufacturers are named under paragraph 45(d) and are the entities whose name appears on the label. Suppliers are everyone else in the chain who sells the device to the establishment, named under paragraph 45(f.1). A foreign distributor that is not the manufacturer belongs on the second list, with the device classes it supplies.
We already send supplier information voluntarily. What changes for us?
The filing becomes mandatory and becomes an annual obligation tied to the licence review under subsection 46.1(1). The regulatory impact analysis statement estimates that about 800 of roughly 2,300 organisations already provide the information voluntarily, so the practical change for those organisations is the update cadence and the need to keep the building addresses in 45(j) aligned with the procedures.
Do we need a separate procedure for each of the five obligations?
The Regulations require procedures for each obligation; they do not prescribe a document structure. Many establishments combine complaint investigation and recall into one procedure, because section 58 covers both, and keep incident reporting separate because the clock in section 60 runs differently. What matters is that each required activity has a written procedure, that staff follow it, and that the records it generates exist.
What happens to an application that is pending when the amendments take effect?
Section 9 provides that a pending application must not result in a licence unless the applicant has provided the supplier information described in paragraphs 45(f.1) and (f.2) before that day, in the form the Minister establishes. The practical step is to prepare that data now if an application is in the queue.
Is the effective date 1 December or 14 December 2026?
1 December 2026. Section 10 provides that the amendments "come into force on the 180th day after the day on which they are registered", and SOR/2026-110 was registered on 4 June 2026. Health Canada's MDCP Bulletin writes 14 December 2026 because it counts those 180 days from publication in the Canada Gazette on 17 June 2026; the bulletin is guidance, while the instrument fixes the date. Have the procedures and the supplier data ready by 1 December 2026.
Does this change the rules for buying sterilization consumables from a Canadian supplier?
Not the product rules. What changes is the documentation a licensed importer or distributor has to hold behind those products, which is why the same distributor may now ask for more supplier detail and more current procedures. Device classification and licensing for the products themselves are unchanged by this instrument.
About the publisher. CliniEco Medical supplies sterilization monitoring and personal protective consumables to Canadian dental clinics, laboratories, veterinary practices and long-term care homes. CliniEco Medical — MDEL #35334. Questions about documentation that accompanies an order can go to +1 (437) 466-2232 or through the institutional account desk.
Sources
- Regulations Amending the Medical Devices Regulations (Establishment Licences): SOR/2026-110, Canada Gazette, Part II, Vol. 160, No. 12 — accessed 17 October 2026
- Medical Devices Regulations (SOR/98-282), consolidated text current to 2026-09-30 — accessed 17 October 2026
- Medical Devices Regulations — amendments not in force — accessed 17 October 2026
- Phase 2 of our work to modernize medical device establishment licensing, MDCP Bulletin, 17 June 2026 — accessed 17 October 2026
- Guidance on medical device establishment licensing (GUI-0016) — accessed 17 October 2026
- Medical device establishment licence application: instructions (FRM-0292) — accessed 17 October 2026
- How Health Canada inspects medical device establishments (GUI-0064) — accessed 17 October 2026
- Canada Gazette, Part II, Volume 160: list of editions and registration numbers — accessed 17 October 2026